$0.1963
0.00945.03%
Ult. Agg.: Nov 6, 6:48 PM
The average analyst price target for 20/20 Biolabs is $5, 2531.6% above the current price. The one analyst covering it rates it Buy. The latest change came on May 11, 2026, when Maxim Group initiated coverage of 20/20 Biolabs with a Buy rating and a $5 price target.
Price Target Range — 1 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months